Human CD4 T cells coordinate antitumor immunity through indirect antigen presentation
Roy, G.; Ruterbusch, M.; Bakhtiari, J.; Shasha, C.; Lee, S. M.; Moshiri, A. S.; Wood, C.; Hopwo, K.; Witkowski, M.; Szeto, J.; Singhi, N.; Iuliano, M.; Guenette, S.; McKenna, K. M.; Newell, E.; Rongvaux, A.; Veatch, J. R.
Show abstract
Whether human tumor-specific CD4 T cells can drive antitumor immunity in cancers lacking tumor-cell MHC class II expression has not been established. In MHC class II-negative melanoma and breast cancer, CD4 T cells with a transcriptional signature of tumor specificity correlated with myeloid and CD8 T cell activation. Using a patient-derived NY-ESO-specific, HLA-DP04-restricted TCR, we tested whether human CD4 T cells could control tumors through indirect antigen presentation. In vitro, CD4 T cells inhibited HLA-DP-negative melanoma growth through recognition of tumor-derived antigen on antigen presenting cells (APC). In humanized mice, CD4 T cell transfer induced regression of HLA-DP-negative tumors, and control required HLA-matched human APCs. CD4 T cell transfer induced endogenous CD8 T cell proliferation and myeloid activation that mirrored immune programs correlated with the presence of these cells in patients. These findings establish that human tumor-specific CD4 T cells coordinate antitumor immunity through APC without direct tumor recognition, supporting their therapeutic relevance in MHC class II-negative cancers.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Intra-Tumoral Treg Ablation Unleashes NK Cell-Mediated Control of CD8 T Cell-Resistant Tumors 95%
- Cellular selectivity of STING stimulation determines priming of tumor-specific T cell responses 94%
- A reservoir of stem-like CD8 T cells in the tumor-draining lymph node maintains the ongoing anti-tumor immune response 93%
Similar papers in this journal
- B cells sustain inflammation and improve survival in human melanoma 96%
- Rapid establishment of a tumor-retained state curtails the contribution of conventional NK cells to anti-tumor immunity in solid cancers 94%
- TGF--dependent Lymphoid Tissue Residency of Stem-like T cells Limits the Response to Tumor Vaccine 94%
Similar papers in this journal
Similar papers in this journal
- Decoy Antibodies Block Extracellular HSP70, Prevent Self Signaling and Inhibit Melanoma Cell Survival 94%
- Neoantigen Cancer Vaccines and Different Immune Checkpoint Therapies Each Utilize Both Converging and Distinct Mechanisms that in Combination Enable Synergistic Therapeutic Efficacy 94%
- Requirements for development of T-helper1 and T-follicular helper cells from a common precursor 94%
Similar papers in this journal
- Tumor-Specific CD8+ T Cells from the Bone Marrow Resist Exhaustion and Exhibit Increased Persistence in Tumor-Bearing Hosts as Compared to Tumor Infiltrating Lymphocytes 94%
- Distinct sets of molecular characteristics define tumor-rejecting neoantigens 94%
- The spontaneous neoantigen-specific CD4+ T cell response to a growing tumor is functionally and phenotypically diverse. 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.